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ABSTRACT 
 The classical definition of genetic cis-regulatory modules such as 
enhancers identifies these elements as insensitive to changes in position and 
orientation relative to the transcription start site (TSS). While this theory is well 
supported, some recent studies have uncovered examples of constraint in the 
position or orientation of particular enhancers. This study examines the position 
and orientation sensitivity of two upstream enhancer elements found in the gene 
Pax6, which regulates development of the eyes and central nervous system in 
vertebrates. Late embryonic stages of the organism used in this study, Ciona 
intestinalis, show expression of Pax6 in the nerve cord and sensory vesicle.  
For this investigation Pax6 constructs were created in which the enhancers 
were repositioned or inverted relative to the TSS. These constructs were 
electroporated into embryos of C. intestinalis, and expression of the Pax6-GFP 
fusion gene was measured both by total fluorescence and by number of positive 
embryos. Alteration of either position or orientation of these enhancers was found 
to cause a strong decrease in measured Pax6 expression. These results support the 
conclusion that the upstream enhancers must be in the proper location and 
arrangement to be fully functional, a finding that is consistent with the results of 
many other studies of cis-regulatory elements. 
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INTRODUCTION 
Enhancers and other cis-regulatory elements 
 The expression of genetic information as traits relies on a group of DNA 
elements collectively referred to as cis-regulatory elements. These DNA elements 
are located on the same strand of DNA as the genes they regulate; the function of 
these elements is to control the degree to which their target genes are expressed as 
well as when during development and in what cells these genes are expressed. 
One type of cis-regulatory element is the enhancer, so named because it increases 
the expression of the target gene (reviewed in Atchison, 1988). An enhancer is 
typically found upstream from the gene it regulates, although some enhancers are 
found downstream of their target genes or within introns of the target genes. 
Regulation of gene expression is accomplished through transcription factors 
(TFs), which are proteins that bind particular DNA elements in order to promote 
or suppress gene expression. Specific TFs bound to the enhancer element will 
form a complex with general TFs bound to the basal promoter, a DNA element 
that marks the start site for the process of transcription (Ptashne, 1986; Ptashne, 
1988). This interaction of specific and general TFs will influence the extent to 
which the target gene is expressed. 
 In the 1980s a number of studies of enhancers and other cis-regulatory 
elements established the theory that these elements are flexible in their position 
and orientation relative to the transcription start site (TSS). These studies 
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examined enhancers from diverse systems, such as Moloney murine sarcoma 
virus (Laimins et al., 1984), hepatitis B virus (Shaul et al., 1985), yeast (Elion and 
Warner, 1986), and the mouse (Jaynes et al., 1988). For each study the enhancers 
for particular genes were repositioned relative to the TSS, reversed in their 
directional orientation relative to the TSS, or both; the amount of expression of 
these genes was then measured and compared to the expression level using the 
default enhancer setup. These studies concluded that the enhancers still 
functioned in an altered position or orientation.  
The results of studies such as these established the idea that enhancer 
function is unaffected by changes to the position and orientation of these 
elements, an idea that eventually became a criterion for establishing a DNA 
element as an enhancer. By the end of the same decade a mechanism had been 
discovered that explained the basis for this flexibility. In this model (Ptashne, 
1986; Ptashne, 1988) the non-coding DNA between an enhancer and the basal 
promoter forms a loop that brings these two elements into close proximity to one 
another. TFs bound to each of these elements are then in the correct position to 
interact and stimulate transcription. Since the size of the loop does not matter, a 
change in enhancer position would affect the size of the loop formed but would 
preserve crucial TF interactions. Similarly, a change in enhancer orientation 
would cause a slightly different loop structure to form but would not affect the 
interactions of TFs. Because the necessary TF interactions are preserved in this 
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model, the level of transcription is not affected by alterations to the enhancer 
position or orientation. 
In many of these same early studies, however, the altered position and 
orientation of the enhancers did appear to reduce the level of expression of these 
genes. Expression from the murine muscle creatine kinase promoter dropped to 
approximately 20% when the upstream enhancer was either moved to a position 
downstream of the reporter gene or inverted (Jaynes et al., 1988). Similarly, an 
enhancer from the long terminal repeat of Moloney murine sarcoma virus was 
found to be only 30 to 40% active when moved downstream of the reporter gene 
(Laimins et al., 1984).  An enhancer from hepatitis B virus (HBV) gave values in 
the range of 50 to 300 in the forward orientation as measured by a 
chloramphenicol acetyltransferase (CAT) assay, while expression using the 
inverted enhancer ranged from 25 to 50 (Shaul et al., 1985). Such results indicate 
that while an enhancer may still be able to function if its position or orientation is 
affected, such alterations to the enhancer do reduce the level of expression to 
some extent. The reduction in enhancer activity found in these studies was 
generally overlooked at the time of these investigations. 
In more recent years there have also been a few studies that have 
uncovered enhancers that do not behave in the traditional way. One such study 
(Kim et al., 2008) examined two cis-regulatory elements in mice. One, the CSE2 
element, is an enhancer that promotes expression of the TF-encoding gene Peg3. 
The other, the CSE1 element, is a silencer for two co-regulated genes, Peg3 and 
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Usp29. Silencers differ from enhancers in that silencers suppress expression of 
their target genes. Silencers also show the same position and orientation flexibility 
as enhancers. This study, however, revealed a near complete loss of regulation of 
the target gene Peg3 when either element was inverted. Inversion of the enhancer 
CSE2 caused a drop in expression from 1.7 fold to 1.1 fold. These numbers are in 
reference to the 1.0 fold expression observed when CSE2 was deleted from the 
DNA. In the case of the silencer CSE1, inversion caused expression to increase to 
2.5 fold. By comparison, deletion of CSE1 gave 2.7 fold expression of Peg3. The 
effect of CSE1 orientation on silencing of Usp29 was not examined in this study.  
Another study in the fruit fly Drosophila melanogaster (Small et al., 
1993) examined the expression of the even-skipped (eve) gene, which controls 
patterns of striping. The eve gene is controlled by several upstream enhancers. 
Correct expression of this gene was found to be dependent on a minimum length 
of sequence separating two of the upstream enhancers; various abnormalities 
result when they are placed too close together. It is important to point out that in 
the eve gene investigation the enhancers are constrained by their positions to each 
other rather than to the TSS. 
In addition to functional studies, several sequence conservation studies 
have identified genes in which the position and orientation of enhancers are 
evolutionarily conserved. Sequence conservation typically indicates that a region 
of DNA has some important function, such as a gene or a cis-regulatory element. 
Similarly, if the orientation of an enhancer or its distance from the TSS is 
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conserved, this may indicate that the observed position or orientation is necessary 
for correct gene expression. One recent sequence conservation study (Goode et 
al., 2005) compared human chromosomal region 7q36 to the genome of the 
pufferfish Fugu rubripes and identified a number of conserved non-coding 
sequence elements in which the position and orientation were conserved. In a 
subsequent functional assay, most of these conserved elements were found to 
function as enhancers. 
The developmental gene Pax6 
 The gene Pax6 plays an important role in development of the eyes and 
nervous system in both vertebrates and invertebrates (reviewed in Simpson and 
Price, 2002, and in Thompson and Ziman, 2011). The Pax6 protein encoded by 
this gene functions as a transcription factor. The Pax family TFs contain an N-
terminal paired domain used in binding target genes and a C-terminal 
transactivation domain that mediates protein-protein interactions; Pax6 also 
includes a DNA-binding homeodomain (Thompson and Ziman, 2011). The 
functions of Pax6 are highly diverse, including roles in patterning of the central 
nervous system (CNS), control of cell migration, expression of cell surface 
adhesion molecules, and promoting both proliferation and differentiation of 
neurons in the eyes and CNS at different stages of development (Simpson and 
Price, 2002; Thompson and Ziman, 2011). The functions of Pax6 differ between 
cell types, due in part to at least two isoforms of the Pax6 protein with different 
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specificities for target genes (Simpson and Price, 2002; Thompson and Ziman, 
2011). 
 Mutations in PAX6 are associated with a variety of phenotypic 
abnormalities in humans. One of these is the autosomal dominant condition 
aniridia, reviewed in (Lee et al., 2008). Aniridia is caused by mutations in PAX6 
that cause premature termination of translation; these are commonly nonsense 
mutations or frameshift insertions or deletions. The reduced level of functional 
PAX6 protein results in improper development and maintenance of the cornea, 
lens, optic nerve, and other components of the eye. This condition can include 
aniridia-associated keratopathy, a corneal disorder that results in dry or red eyes, 
photophobia, increased watering of the eyes, and vision loss. Aniridia can also 
lead to glaucoma due to improper drainage. PAX6 mutations have been implicated 
in other eye disorders such as keratitis, certain cataracts, and Peter’s anomaly 
(Simpson and Price, 2002; Thompson and Ziman, 2011). Animal models with 
Pax6 mutations show various eye and brain disorders such as an aniridia-like 
small eye, also known as microphthalmia (Simpson and Price, 2002; Thompson 
and Ziman, 2011). Abnormal phenotypes may result from loss of expression or 
overexpression of Pax6, indicating that proper Pax6 function is concentration-
dependent (Simpson and Price, 2002; Thompson and Ziman, 2011). 
 Pax6 was chosen as the gene of interest in this project for several reasons. 
Since the function of Pax6 is widespread and very sensitive to concentration of 
the protein, any change in Pax6 expression as a result of an altered cis-regulatory 
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module could cause a harmful phenotypic change. There have also been many 
studies of cis-regulation of Pax6 and its homologs in various systems such as the 
mouse (Xu et al., 2002; Kleinjan et al., 2004; Kleinjan et al., 2006; Kammandel et 
al., 1999), fruit fly (Adachi et al., 2003; Hauck et al., 1999), and others (Griffin et 
al., 2002; Kammandel et al., 1999; Plaza et al., 1999). These studies allow 
comparisons of effects on cis-regulation to be made across diverse species. In 
addition, the Irvine lab has previously identified the major cis-regulatory regions 
that appear to be necessary for Pax6 expression in Ciona intestinalis (Irvine et al., 
2008). 
The model organism Ciona intestinalis 
 The organism used in this study is the sea squirt Ciona intestinalis, 
discussed in (Satoh, 1994). Sea squirts, or ascidians, are ubiquitous in marine 
environments worldwide (Satoh, 1994). The adults are sessile filter feeders with a 
tube- or barrel-shaped body. The body has two tubular openings: an oral siphon 
that takes in food and oxygenated water, and an atrial siphon that expels waste 
and deoxygenated water (Satoh, 1994). Ciona is a hermaphroditic organism but is 
self-sterile; fertilization requires gametes from different individuals. The embryos 
of C. intestinalis include tailbud stages that resemble tadpoles; these embryos are 
the focus of this study. 
C. intestinalis is an ideal choice for studying expression of transgenes for 
several reasons (reviewed in Satoh et al., 2003). First, a simple electroporation 
method has been developed to introduce a single transgene into large numbers of 
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fertilized C. intestinalis eggs (Corbo et al., 1997). In addition, a second draft of 
the C. intestinalis genome has been published (Dehal et al., 2002). Comparison of 
sequences between C. intestinalis and the closely related species C. savignyi has 
proven to be an effective tool for locating conserved non-coding DNA elements 
such as enhancers (Johnson et al., 2004; Irvine et al., 2008; see Figure 1). 
Furthermore, embryos of C. intestinalis are transparent and have a relatively small 
number of cells; the cells are large and easily distinguished under a microscope. 
The developmental fates of all cells in the early embryonic stages of this organism 
have been well documented. This means that expression patterns of transgenes 
introduced by electroporation can be directly observed and measured at any of the 
various embryonic stages, and that these results can be collected in a cell- or 
tissue-specific manner. 
Hypothesis 
Since many previously studied enhancers show some sensitivity to 
changes in position or orientation, it is worth investigating whether this 
phenomenon is common among cis-regulatory DNA elements. This investigation 
focuses on two enhancer elements, named UB and UA, located approximately 1.8 
kb upstream of the TSS of the C. intestinalis Pax6 (CiPax6) gene; Figure 1 shows 
the locations of cis-regulatory elements identified in CiPax6. These two 
enhancers work synergistically to form a single cis-regulatory module. Here I 
present evidence that the UB-UA enhancer cassette loses much of its regulatory 
function when inverted or moved closer to the TSS. These results are similar to 
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Figure 1. Conserved functional regions in CiPax6. A VISTA plot of conserved 
sequence regions between Ciona intestinalis and Ciona savignyi is shown above a 
diagram of major functional regions identified in the CiPax6 gene. CiPax6 
contains four regions with experimentally confirmed cis-regulatory functions, 
shown in this diagram as pink ovals. The upstream UB and UA enhancer elements 
promote expression of Pax6 in the nerve cord and in the sensory vesicle of the 
brain. A third enhancer within the first intron promotes expression in the 
photoreceptor cells and the nerve cord. The element within the fourth intron acts 
as a silencer. Image taken from (Irvine et al., 2008).
 10
observations from other enhancer elements, suggesting that this phenomenon of 
position and orientation sensitivity is more common in enhancers than previously 
recognized.
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METHODS 
Production of test vectors 
Vector Lig 1 was produced from the experimental vector CiP6-2.5UI1 
used and discussed in Irvine et al., 2008. CiP6-2.5UI1 contains a portion of the 
CiPax6 gene beginning 2.5 kb upstream of the TSS and ending within the first 
exon. This fragment includes the upstream UB and UA enhancer elements 
followed by approximately 1.8 kb of non-coding DNA separating the enhancers 
from the TSS. The intron 1 enhancer, which promotes expression in the nerve 
cord and photoreceptor cells (Irvine et al., 2008), is also included in this vector. 
CiP6-2.5UI1 also contains a nuclear localization signal (NLS), lacZ reporter gene 
sequence, and a SV40 polyadenylation signal. Lig 1 was created by replacing the 
lacZ reporter sequence with GFP cDNA. 
Lig 2 was intended to be a vector with the upstream enhancer cassette 
inverted in orientation. This vector was not successfully produced, however; 
therefore the discussion of this vector is skipped in this thesis. 
Lig 3 was produced by digesting vector 1 with ClaI and NruI to remove a 
1.15-kb piece of DNA from between the upstream enhancers and TSS. The piece 
of DNA removed from this clone was a piece of non-coding, non-conserved DNA 
that was believed to exclude any TF binding sites from the enhancers or the basal 
promoter. The ClaI overhang was blunted with T4 DNA polymerase, and the 
vector was ligated. 
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GW 1, GW 2, and GW 3 were produced using the Gateway recombination 
system (Invitrogen). These vectors were designed to be similar to Lig 1, Lig 2, 
and Lig 3, respectively; however, the vectors produced through the recombination 
method include attB recombination sites at both ends of the enhancer cassette. 
The production of comparable vectors by two different methods was used to 
check that any effects observed was not an artifact of the way in which the 
plasmids were made. Prior to the production of these vectors, the intermediate 
vector Aux 1 was produced. Aux 1 was prepared by digesting Lig 1 with AscI and 
HindIII, which removed a 19 base pair fragment immediately upstream of the 
enhancers. A Gateway recombination cassette was ligated into this site to produce 
Aux 1.  
Next the entire vector except the enhancer region was amplified by PCR 
using primers that bind outside the enhancer region. This PCR product was then 
phosphorylated with T4 polynucleotide kinase and ligated. The product of this 
reaction, Aux 2, was used as the destination vector in the generation of vectors 
GW 1 and GW 2.  
To produce GW 1, a copy of the enhancer cassette was first amplified with 
attB recombination sites at both ends. This product was used in a BP reaction with 
the vector pDONR221 (Invitrogen) to produce an entry vector with the enhancer 
cassette in the forward orientation. This entry vector was then used in a LR 
reaction with Aux 2, resulting in production of GW 1. GW 2 was produced 
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through a similar strategy, but the entry vector contained the enhancer cassette in 
the flipped orientation. 
The destination vector for production of GW 3 was generated by digesting 
Aux 1 with AscI and NruI. This reaction removed a segment that was 1922 bases 
in length on the coding strand. The 5’ overhang left by AscI was filled using T4 
DNA polymerase, and the vector was ligated to produce Aux 3. This new 
destination vector was used in a LR reaction with the previously mentioned entry 
vector containing the enhancers in the forward orientation, resulting in the 
production of vector GW 3. 
The upstream promoter regions of all plasmids tested in this investigation 
are diagrammed in Figure 2. 
Collection and quantification of DNA 
 Plasmids were transformed into chemically competent TOP10 E. coli. 
DNA was harvested from overnight cultures by midiprep. For quantification, 
samples of known volumes of each plasmid were digested with XhoI, which cuts 
at a single site upstream of the enhancers. Concentrations of the linear vectors 
were determined on agarose gels using the GeneTools software from SynGene. 
Fertilization and transformation of embryos 
 Adult animals were obtained locally from the Point Judith Marina at Snug 
Harbor, Rhode Island, or purchased from M-Rep, Carlsbad, California. Gametes 
were collected from adult animals by dissection, and fertilization was performed 
in vitro.
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Figure 2. Maps of experimental and intermediate vectors. Relevant sequence 
elements are shown, beginning with enhancers and ending with GFP transgene. 
Distances represented are not drawn to scale. Arrows above enhancers represent 
orientation; right is forward and left is reversed. (A) Lig 1 is the positive control 
for ligation-generated vectors. (B) Lig 3 contains the upstream enhancers at a 
distance of 0.6 kb from the TSS. (C) GW 1 is the positive control for 
recombination-generated vectors. (D) GW 2 contains the enhancer cassette in the 
reversed orientation. (E) GW 3 contains the enhancer cassette at a distance of 0.5 
kb from the TSS. (F-H) The Aux vectors were intermediates used to produce the 
tested vectors. They are described in the Methods section and are therefore 
included in this figure.
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Dechorionation and electroporation were performed 10 minutes after the 
completion of fertilization. The protocol used was a modified version of a 
previous protocol used by the Irvine lab (Vierra and Irvine, 2012). Briefly, 
fertilized eggs were dechorionated using 0.4 mg/ml Pronase E in 1% sodium 
thioglycolate in 3.3% sodium chloride pH 10.1 for 3 to 5 minutes at 18°C. 
Dechorionation was quenched by transferring eggs to 1 mM glycine in phosphate 
buffered saline (PBS). For each electroporation, 250 µl of eggs in filtered 
seawater (FSW) were added to a solution containing 50 µg of DNA in 100 µl of 
water and 350 µl of 1 M mannitol. Electroporation was performed using a BTX 
ECM 830 square wave electroporator. The settings for all electroporations were 
32 V, 100 ms. Actual voltage ranged from 20 V to 30 V, with nearly all samples 
electroporated at 27 V or 30 V; all electroporation times were 100 ms. Following 
electroporation, embryos were raised in gelatin-coated dishes of FSW containing 
approximately 15 U/ml penicillin and 15 µg/ml streptomycin. The rearing 
temperature used was 14°C. 
Embryo fixation 
 All embryos were fixed for analysis at late tailbud stage 1 or 2, around 18 
to 22 hours post fertilization when raised at 14°C. Embryos were fixed for 10 min 
in 2% paraformaldehyde in the dark. After removal of fixative, embryos were 
incubated in 100 mM glycine in PBS for 30 min to reduce autofluorescence of 
muscle cells. Glycine was then washed out three times with either PBS or PTw 
(PBS + Tween 20), and embryos were left in PTw until the time of analysis. 
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Photography of embryos 
 In preparation for analysis, embryos were incubated in PBS for 30 min; 
this PBS served as the mounting medium for microscopy. Slides were prepared by 
placing two layers of Scotch tape on each side of the slide, to the left and right of 
where the embryos would be placed. The two layers of tape served the purpose of 
preventing the embryos from being crushed when a cover slip was placed over 
them. After the tape was added, the surfaces of the slides and tape were greased 
with Rain-X except in the middles, where the embryos were to be placed. The 
slides were then cleaned with Windex. Embryos were mounted in a small drop of 
PBS between the taped areas of each slide. A cover slip was then laid over the 
embryos such that the edges of the cover slip were held up by the tape.  
Embryos were viewed by epifluorescence illumination microscopy. Each 
embryo was photographed under a GFP filter using a SPOT Flex digital camera 
(Diagnostic Instruments). The image setting for all embryos were as follows: 
fluorescence as the image type, manual exposure, and 251.6 ms as the exposure 
time. All other settings were left as default. Embryos were photographed within 
three days after fixation. 
Data analysis 
All embryos were visually scored for expression or lack of expression of 
the reporter gene GFP using the following definitions. A positive score means 
that the embryo showed fluorescence in the sensory vesicle above the normal 
level of autofluorescence, fluorescent nuclei along the nerve cord, or fluorescence 
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in both locations. A negative score means that no increase in fluorescence was 
detected in the nerve cord or sensory vesicle. A score of ambiguous means that 
there appeared to be a slight increase in fluorescence observed in the sensory 
vesicle or increased fluorescence in the nerve cord without confirmed nuclear 
localization, but that the observed fluorescence was not definitely attributable to 
GFP. 
Embryos were also measured for green fluorescence using the program 
ImageJ. For this analysis embryo photographs were first converted to grayscale in 
Adobe Photoshop. These images were too dim to be visible, so the white input 
level was reduced from 255 to 30 for each photograph using Photoshop. The 
adjusted images were then opened in ImageJ. For each photograph four 
measurements were performed. The first measurement was of the entire embryo 
or the trunk portion of the embryo, as specified in the results of each analysis. The 
next three measurements were square sections of the background fluorescence. 
All measurements included the values of area, mean gray value, and integrated 
density. Integrated density is the sum of the gray values of all pixels in the 
measured area; mean gray value is the average intensity per pixel in the measured 
area.  
Whole embryo measurements were corrected for autofluorescence using a 
set of negative control embryos photographed the same number of days after 
fixation as each experimental or positive control embryo. The negative control for 
each trunk measurement was a section of autofluorescence from the trunk of the 
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same photograph. The mean gray value for the negative control was subtracted 
from the mean gray value of the embryo being measured to give the corrected 
density. These corrected density values were averaged for all embryos in each 
trial. Corrected mean density values are presented as both raw values and 
normalized values. Vector Lig 3 was normalized against Lig 1, while vectors GW 
2 and GW 3 were normalized against GW 1; normalized values are given as 
percentages of expression relative to Lig 1 or GW 1 from the same set of trials. 
Statistical analysis was performed on all raw data using Student’s t-test. 
For the statistical analysis each experimental trial was compared to the positive 
control from the same trial set; the Lig 1 and GW 1 trials were also compared. All 
t-tests were 2-tailed and assumed unequal variance. The assumption of unequal 
variance was made because there was variability in the observed GFP 
fluorescence and autofluorescence between trials. The F-test for each statistical 
comparison was also performed to examine the variance. F-values were calculated 
offline, then p-values were calculated using the Free p-Value Calculator for an F-
Test at (http://www.danielsoper.com/statcalc3/calc.aspx?id=7). Calculated p-
values for the F-test ranged from 0.019 to 0.495. 
For each comparison using the t-test, the p value was calculated using the 
online T-Test Statistics Calculator at (http://studentsttest.com/). Results of the t-
test are presented on each graph. The definitions of these statistical results are as 
follows. A dash (-) represents a p value of 0.05 or greater. One star (*) represents 
a p value between 0.05 and 0.005. Two stars (**) represents a p value between 
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0.005 and 0.0005. Three stars (***) represents a p value less than 0.0005. For this 
investigation a p-value of less than 0.05 is considered statistically different.
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RESULTS 
 Constructs in which the position or orientation of upstream enhancers 
has been altered show visibly reduced expression of GFP in C. intestinalis 
embryos as compared to the positive control constructs. Table 1 shows the 
number and percentage of embryos from each trial that were scored as positive, 
ambiguous, and negative. Lig 1 and GW 1 are positive controls for the ligation 
and recombination methods of vector production, respectively. In two separate 
trials 100% of embryos containing Lig 1 were positive; GW 1 yielded 93% 
positive and 7% ambiguous embryos in one trial and 100% positive embryos in 
another. All positive control embryos showed strong GFP expression in the 
sensory vesicle, and some showed nerve cord expression from either positive 
control; embryos containing Lig 1, but not GW 1, also showed non-nuclear 
expression in muscle cells in the tail. The expression in the tail muscle cells is 
assumed to be ectopic, since all plasmids used in this investigation encode GFP 
with a nuclear localization signal. Figure 3 contains representative photographs of 
embryos electroporated with each construct. The two ambiguous embryos 
containing GW 1 show slightly higher fluorescence in the sensory vesicle than the 
no-DNA controls, and although they cannot be conclusively scored as positive, 
they are predicted to be expressing GFP at a low level. These high percentages of 
positive embryos confirm that both of the positive control vectors drive 
expression of GFP.
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Construct n # (+) % (+) # A % A # (-) % (-) 
Lig 1-1 11 11 100 0 0 0 0 
Lig 1-2 3 3 100 0 0 0 0 
Lig 3-1 23 7 30 6 26 10 43 
Lig 3-2 5 1 20 1 20 3 60 
GW 1-1 30 28 93 2 7 0 0 
GW 1-2 26 26 100 0 0 0 0 
GW 2-1 26 0 0 3 12 23 88 
GW 2-2 9 2 22 4 44 3 33 
GW 3-2 10 0 0 5 50 5 50 
(-) C-2 12 0 0 0 0 12 100 
 
 
Table 1. Quantification of embryos expressing GFP.  All embryos were scored 
as positive [(+)], negative [(-)], or ambiguous (A) for GFP expression. Scores for 
each trial are given as number (#) and percentage (%) of embryos in each 
category; n refers to the total number of embryos in each trial. Trials are labeled 
with the name of the plasmid used, followed by a hyphen, then the number of the 
trial set; this trial naming system is also used in certain places in the text. All trials 
with the same trial set number were performed simultaneously. (-) C-2 is the no-
DNA negative control used in trial set 2. 
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(D)        (E)              (F) 
                 
 
(G)        (H) 
       
 
Figure 3. Representative photographs from trials with each plasmid. All 
images have been scaled to 25% of the original height and width in Photoshop. 
(A-C) These photographs have been enhanced by decreasing maximum RGB 
input levels from 255 to 20 to reproduce the appearance under the microscope. 
Areas of GFP expression are indicated by arrows and the following labels: SV, 
sensory vesicle; NC, nerve cord; E, ectopic expression. (A) Lig 1 embryo; nerve 
cord expression is occurring but is not visible. (B) GW 1 embryo showing 
fluorescent nuclei in the nerve cord. (C) Negative control embryo containing no 
DNA; control for autofluorescence. 
(D-H) These images have been converted to grayscale, and the white input level 
has been reduced from 255 to 15. (D) Lig 1 embryo. (E) Lig 3 embryo. (F) GW 1 
embryo. (G) GW 2 embryo. (H) GW 3 embryo.
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Construct GW 2 contains the upstream enhancers in the flipped 
orientation. The results of two trials with this vector were somewhat mixed. The 
breakdown of embryos from one trial with GW 2 was 12% ambiguous and 88% 
negative, but a second trial gave 22% positive, 44% ambiguous, and 33% 
negative embryos. Most GW 2-containing embryos scored as ambiguous showed 
weak non-nuclear fluorescence in the nerve cord, which usually shows no 
autofluorescence. However, some control embryos containing no transgene 
showed similar fluorescence. These results for GW 2 indicate that the flipped 
enhancers are less effective at promoting GFP expression than the same 
enhancers in the default orientation. A lack of visible expression in most embryos, 
however, does not rule out the possibility of low levels of GFP that are invisible 
to the unaided eye. 
 Constructs Lig 3 and GW 3 have the upstream enhancers moved closer to 
the TSS. Lig 3 yielded 30% positive and 26% ambiguous embryos in one trial; a 
second trial yielded 20% positive and 20% ambiguous embryos. Most of the 
positive embryos were weakly positive; these data suggest that Lig 3 promotes a 
low level of GFP expression that is visible in some embryos but not in others. The 
data for GW 3 do not match those of Lig 3. One trial was performed with GW 3, 
in which 50% of embryos were scored as ambiguous and 50% were scored as 
negative. The ambiguous embryos showed non-nuclear fluorescence in the nerve 
cord only, which makes them more likely to be negative. GW 3 therefore does not 
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promote expression of GFP to a visible level using the methodology of this 
investigation. 
 There is a modest difference in measured GFP expression from GW 1 
versus from Lig 1. Embryos were analyzed for fluorescence using ImageJ, as 
described in the Methods section of this thesis. For trial set 2 the negative control 
was a set of embryos that were fertilized, dechorionated, and fixed alongside these 
trials, but were not electroporated and did not receive any foreign DNA. A no-
DNA control was not available for trial set 1, so Lig 2-1 was used as the negative 
control for this set of trials. This decision was made because Lig 2-1 gave the 
lowest corrected mean density value and because nearly all embryos in this trial 
were scored as negative for visible GFP expression.  
Figure 4 shows corrected mean density values for all whole embryo trials 
performed. In trial set 1, Lig 1 gave a mean value of 899 ± 526 while GW 1 gave 
a mean value of 647 ± 632. The values from trial set 2 were 1394 ± 126 for Lig 1 
and 998 ± 614 for GW 1. This increased fluorescence in trial set 2 relative to trial 
set 1 was, in general, consistent among individual positive control embryos. 
Normalized values and statistical analysis for the positive controls are shown in 
Figure 5. In both trial sets the normalized mean value of GW 1 is approximately 
72% that of Lig 1 in spite of the differences in raw mean values between trial sets. 
This difference was determined to be statistically significant for trial set 2 (p = 
0.012) but not for trial set 1 (p = 0.213). 
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Figure 4. Raw fluorescence values from whole embryo analysis. All constructs 
except GW 3 were tested in two separate trials; values from trial set 1 are given in 
blue, and values from trial set 2 are given in red. Results of t-tests follow the same 
color coding. Trial GW 2-2 gave a negative value but is represented as zero in this 
graph. Error bars represent the standard deviation of each trial.
 26
 
 
 
Figure 5. Normalized fluorescence of controls, whole embryo analysis. 
Corrected mean density values of the positive control trials from the whole 
embryo analysis were normalized against Lig 1. For each construct values from 
trial set 1 are given in blue, and values from trial set 2 are given in red. Results of 
t-tests follow the same color coding. The statistical results shown in this graph 
were taken from the raw data, not the normalized values.  
Error bars represent a combined standard deviation for the trial and the control 
against which it was normalized. For the combined standard deviation the 
standard deviations of the individual trials were treated as random error and 
propagated as follows. Standard deviations were first converted to percentages of 
the trial mean. These percent error values were squared, and the two squares were 
added. The square root of this sum was then taken to get the relative standard 
deviation as a percentage of the normalized mean. This percentage was then 
multiplied by the normalized mean to give the combined standard deviation.
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All experimental constructs yield lower levels of GFP expression than 
positive control constructs as measured by ImageJ. Figure 4 shows that all 
experimental constructs show lower corrected mean density values than the two 
positive controls. Normalized values for the experimental trials are given in 
Figure 6. The two trials with GW 2 gave mixed results. GW 2-1 gave a mean 
value of 460 ± 632, which is approximately 71% of the mean value for GW 1-1. 
The mean value of GW 2-2 was measured as -546 ± 442. This mean value was 
displayed as zero in Figure 4; the standard deviation was not changed. The t-test 
identified the difference between GW 2 and GW 1 as highly significant for trial 
set 2 (p = 1.6 × 10-7) but not significant for trial set 1 (p = 0.274). These GW 2 
measurements do not correlate with the visual observations recorded in Table 1; 
no positive embryos were seen in GW 2-1, but GW 2-2 gave 22% weakly positive 
embryos. This difference is most likely due to lower average autofluorescence in 
GW 2-2. Autofluorescence varied between trials and between embryos within 
each trial. Most of this autofluorescence was naturally occurring green 
fluorescence in muscle cells in the tails of the embryos, although the trunks also 
showed some autofluorescence. In trials where there was very little or no GFP 
expression, some embryos gave negative corrected density values due to low 
autofluorescence. All nine embryos in GW 2-2 gave negative values, producing a 
negative mean value for the trial.  
Removal of most of the non-coding sequence from between the enhancers 
and TSS also caused a loss of measured total fluorescence, although this loss was 
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Figure 6. Normalized fluorescence of experimental embryos, whole embryo 
analysis. Corrected mean density values from Figure 4 were normalized against 
the corresponding positive control as described in the Methods section. Values are 
shown as a percentage of Lig 1 or GW 1 from the same trial set. Values from trial 
set 1 are given in blue, and values from trial set 2 are given in red. Results of t-
tests follow the same color coding. The statistical results shown in this graph were 
taken from the raw data, not the normalized values. 
Trial GW 2-2 gave a negative value but is represented here as a zero on the chart. 
Error bars represent a combined standard deviation for the trial and the control 
against which it was normalized. See figure 5 for an explanation of how the 
combined standard deviations were calculated.
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less dramatic than that caused by inversion of the enhancer cassette. Two trials 
with Lig 3 yielded raw mean values of 370 ± 389 and 486 ± 784. These values are 
41% of Lig 1-1 and 35% of Lig 1-2, respectively. This loss of expression is 
statistically significant for the first trial set (p = 0.010) but not the second trial set 
(p = 0.060). While these trials suggest a substantial decrease in GFP expression 
from Lig 3, the visual observations of these embryos suggest that the actual 
decrease in expression is greater. Trial GW 3-2 gave a raw score of 332 ± 650, 
which is 33% the level of expression from GW 1-2. This result was statistically 
significant (p = 0.013). The relatively high score from this trial appears to be due 
mainly to autofluorescence, since no positive embryos were observed in this trial. 
All trials showed rather high standard deviations, as shown in Figure 4. In 
general, embryos within each trial showed substantial differences in corrected 
mean density, although these values were more or less evenly distributed around 
the average. Two factors that contributed to this high variability in the data were 
autofluorescence and background fluorescence, both of which differed from 
embryo to embryo. Autofluorescence is mainly due to naturally occurring green 
fluorescence in muscle cells. Background fluorescence occurs in the mounting 
medium and can be due to certain fluorescent particles or compounds present 
around the embryo. The combined mean density of autofluorescence and 
background fluorescence was much larger than the mean density from the true 
fluorescent signal in all trials. Small differences in either or both of these sources 
of fluorescence could therefore cause large variations in the corrected mean 
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density values. Another source of error that affected all trials was the positioning 
of embryos. Not all embryos were positioned correctly for a single photograph to 
capture the whole embryo in focus. Parts of the embryo that were out of focus 
became blurry and gave a diffuse fluorescent signal, which resulted in a lower-
than-expected fluorescence measurement. A final source of error that may have 
affected all embryos except the negative controls was mosaic expression of the 
transgene. Following electroporation, depending on how the transgenic plasmid is 
distributed in the egg, it will be partitioned unevenly between cells as the embryo 
develops. This will cause variation in how much DNA is present in regions that 
normally express Pax6. 
Measurements of fluorescence in only the trunk portions of embryos 
give a clearer confirmation of loss of expression in all experimental embryos. 
Most of the GFP fluorescence in these trials is found in the sensory vesicle of the 
brain (Irvine et al., 2008; Figure 3), while the strongest autofluorescence is seen 
in the tail (Figure 3C). In order to reduce the impact of autofluorescence on the 
data collected, the photographs were also analyzed by measuring only the 
fluorescence in the trunk portions of the embryos. Measurements were taken in 
the same manner as in the whole embryo analysis except that a different method 
was used to correct for autofluorescence. In this analysis each embryo 
measurement was individually corrected for autofluorescence by measuring a 
portion of the trunk excluding the brain and using this mean density value as the 
control for autofluorescence. The corrected mean density scores from the trunk 
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based analysis are given in Figure 7. Normalized scores from this analysis are 
given for the positive controls in Figure 8 and for the experimental trials in Figure 
9. 
Using this method the corrected mean density values for Lig 1 were 1293 
± 520 and 2044 ± 474 in trial sets 1 and 2, respectively. The higher values seen in 
the trunk based analysis versus the whole embryo analysis are due to a 
combination of more concentrated GFP signal in the trunk and lower 
autofluorescence. The two trials with the control GW 1 gave corrected mean 
values of 837 ± 385 for trial 1and 1229 ± 393 for trial 2. These values are 65% 
and 60% of the corresponding Lig 1 values, respectively. The difference in 
expression between the controls was statistically significant for trial 1 (p = 0.019) 
but not for trial 2 (p = 0.086). 
As in the whole embryo analysis, the trunk-based analysis revealed lower 
fluorescence in all experimental constructs than in the two positive controls. GW 
2 gave values of 104 ± 521 in trial set 1 and 657 ± 190 in trial set 2. These values 
are 12% and 53% of GW 1, respectively. This loss of expression is statistically 
highly significant for both trial set 1 (p = 4.2 × 10-7) and trial set 2 (p = 3.3 × 10-
6). These results do not match up with the whole embryo results, for which trial 1 
was measured at 71% of the control and trial 2 gave a negative value. The visual 
observations of positive GW 2 embryos agree with the results of the trunk-based 
analysis, not the whole embryo analysis. Lig 3 gave values of 517 ± 312 in trial 1 
and 829 ± 272 in trial 2. The normalized values for this construct are 40% and
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Figure 7. Raw fluorescence values from trunk based analysis. Raw corrected 
mean density values for all trials performed, determined for trunk portions of 
embryos. For each construct values from trial set 1 are given in blue, and values 
from trial set 2 are given in red. Results of t-tests follow the same color coding. 
The negative control from trial set 2 was included in the trunk based analysis and 
is labeled (-) C. Statistical analysis is not shown for the negative control in order 
to maintain readability. Error bars represent the standard deviation of each trial.
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Figure 8. Normalized fluorescence of controls, trunk based analysis. 
Corrected mean density values of both positive controls from the trunk-based 
analysis were normalized against Lig 1. Values from trial set 1 are given in blue, 
and values from trial set 2 are given in red. Results of t-tests follow the same 
color coding. The statistical results shown in this graph were taken from the raw 
data, not the normalized values. 
Error bars represent a combined standard deviation for the trial and the control 
against which it was normalized. See figure 5 for an explanation of how the 
combined standard deviations were calculated.
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Figure 9. Normalized fluorescence of experimental embryos, trunk based 
analysis. Corrected mean density values for trunk based analysis were normalized 
against the corresponding positive control as described in the Methods section. 
Values are shown as a percentage of Lig 1 or GW 1 from the same trial set. 
Values from trial set 1 are given in blue, and values from trial set 2 are given in 
red. Results of t-tests follow the same color coding. The statistical results shown 
in this graph were taken from the raw data, not the normalized values. 
The negative control from trial set 2 is included and is labeled as (-) C. Statistical 
analysis is not shown for the negative control in order to maintain readability. 
Error bars represent a combined standard deviation for the trial and the control 
against which it was normalized. See figure 5 for an explanation of how the 
combined standard deviations were calculated.
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41%, respectively. This loss of expression is highly significant for trial set 1 (p = 
4.8 × 10-4) and significant for trial set 2 (p = 0.030). The trial with GW 3 gave a 
value of 515 ± 296, which is 42% of GW 1-2. This result was statistically highly 
significant (p = 6.6 × 10-6). All of these values for Lig 3 and GW 3 match up 
fairly closely with the whole embryo results, further supporting the conclusion 
that moving the Pax6 upstream enhancers closer to the TSS reduces expression to 
about 30 to 40% of the normal value.  
The negative control set of embryos from trial set 2 was also analyzed by 
the trunk-based method; these results appear in Figure 7 and Figure 9. The raw 
score for this negative control set was 290 ± 304. This value comes out to 14% of 
Lig 1-2 or 24% of GW 1-2; the measurement shown in Figure 9 is normalized 
against Lig 1-2. This result was statistically very significant based on the t-test 
result (p = 3.3 × 10-9). For a no-DNA control this value is somewhat high. The 
reason for this high value is that the embryos show higher autofluorescence in the 
brain than in the rest of the trunk, and the brain is intentionally excluded from the 
autofluorescence measurements. This means that the true GFP fluorescence 
values are likely to be lower than the measured values for all embryos.
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DISCUSSION 
CiPax6 upstream enhancers show sensitivity to changes in their 
position and orientation. Based upon the results of this study, changes in either 
the position of the UB-UA enhancer cassette or its orientation severely reduce or 
eliminate expression of GFP. The effect of altering the orientation of these 
enhancers is a substantial loss of expression; two trials using GW 2 gave 
normalized fluorescence values of 12% to 53% of the corresponding controls 
using the more reliable trunk based measurements. Repositioning the enhancer 
cassette 500 to 600 bp upstream of the TSS also severely reduces expression of 
GFP, but there is still visible expression in some embryos transformed with Lig 3. 
All three trials using either Lig 3 or GW 3 gave normalized values within the 
range of 33% to 42% of the appropriate positive control based on both whole 
embryo measurements and trunk based measurements. 
The inability to avoid autofluorescence during the data analysis was a 
limiting factor in this study, particularly in the whole embryo analysis. The ideal 
solution to this problem would be to analyze only the sensory vesicle and nerve 
cord, thereby avoiding nearly all autofluorescence. However, these regions 
generally were not distinguishable unless there was very strong GFP expression. 
For this reason analysis of only the nerve cord and sensory vesicle would have 
required additional labeling of these regions in experimental and negative control 
embryos. This technique was not used in this investigation but could be applied to 
future analyses. 
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One issue that should be addressed from these results is the observation 
that there was a consistent difference in GFP expression between the positive 
controls Lig 1 and GW 1. GW 1 gave fluorescence values that were 
approximately 70% of Lig 1 fluorescence based on whole embryo measurements 
or 65% based on trunk measurements. The only sequence differences between 
these two vectors are a single base deletion in Lig 1 and differences at the 5’ and 
3’ ends of the enhancer cassette. Differences at the 5’ and 3’ ends include 
remnants of the recombination cassette used in the Gateway method, including an 
attB1 site at the 5’ end and an attB2 site at the 3’ end; as well as a 12 bp stretch of 
DNA found in Lig 1 that is missing from GW 1. The 5’ difference does not affect 
the region previously identified as enhancer sequence. In addition, Lig 1 gives the 
highest level of expression of all vectors tested, so the single base deletion found 
in this vector cannot be responsible for the loss of expression seen in the other 
constructs. Therefore the difference at the 3’ end of the enhancer cassette appears 
to be the only explanation for the reduction in expression from GW 1. The 
locations of the two enhancers were previously determined by a series of PCR-
based deletions from the 5’ end of the upstream sequence (Irvine et al., 2008). 
The study did not make use of 3’ deletions to determine the TSS-proximal end of 
the enhancer cassette; instead this 3’ boundary was identified from the minimum 
sequence whose deletion eliminated detectable expression of GFP. This leaves 
the possibility that the real 3’ edge of the UA element is actually downstream of 
the predicted position, and that this element has consequently been interrupted in 
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GW 1 as well as all experimental constructs. The Irvine lab is currently working 
on the production of new experimental constructs that retain additional sequence 
at the 3’ end of the enhancer cassette. Another possibility, discussed more in the 
next section of this discussion, is that the sequences flanking the enhancer cassette 
somehow modify the activity of the enhancers (Elion and Warner, 1986). While 
this may explain the modest loss of expression in GW 1, there appears to be an 
additional and much greater loss of expression when the position or orientation of 
the enhancers is also altered. 
Other examples of position or orientation sensitivity have been 
documented but have often been overlooked. Many studies, including those 
referenced in this thesis, have found some loss of enhancer activity when the 
position or orientation of an enhancer element is altered. One clear example of 
orientation sensitivity already mentioned in the introduction was the study of two 
cis-regulatory elements of the Peg3 and Usp29 bidirectional promoter (Kim et al. 
2008). The enhancer CSE2 consists of a series of binding sites for the TF YY1; 
the CSE1 element is a silencer for both Peg3 and Usp29. Both of these elements 
are found within the first intron of Peg3. In this study the expression of a reporter 
gene was measured at 1.7 fold when both the CSE1 and CSE2 elements were 
present. The expression level was defined as 1.0 fold for a construct containing 
the silencer CSE1 but not the enhancer CSE2. Inversion of the entire CSE2 
element gave a 1.1-fold level of expression; a similar value was observed when all 
YY1 sites were abolished by mutation. This was interpreted by the authors of the 
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article as orientation dependence of this element. The CSE1 element was also 
found to be orientation sensitive. A construct containing CSE2 but not CSE1 gave 
a 2.7-fold level of expression due to the loss of silencer function of CSE1 in the 
reverse orientation. Inversion of CSE1 (with no alteration to CSE2) gave an 
expression level of 2.5 fold, suggesting that its silencer activity was nearly 
completely lost in the reverse orientation. The CSE1 element was also tested in a 
different location, 3’ of the Peg3-differentially methylated region (DMR) where 
the enhancers are normally found. The expression with CSE1 in this new position 
was about 1.4 fold with CSE1 in the forward orientation and 1.8 fold with CSE1 
in the reverse orientation, which showed that this silencer was fully functional, 
perhaps slightly more functional, in the altered position. 
The study by Small et al. (1993) uncovered an example of extreme 
position sensitivity of two enhancers in the eve gene in Drosophila, as mentioned 
in the introduction. The eve gene controls the proper patterning of segmentation 
stripes in the Drosophila embryo. Stripes 2 and 3 are under the control of separate 
upstream enhancers; these two enhancers are separated by a 1.7 kb spacer of non-
coding DNA. It was discovered that this 1.7 kb fragment could be removed and 
replaced with a different spacer without altering the stripe pattern produced. The 
spacer fragment used could even be of a different size than the natural 1.7 kb 
fragment; one fragment that preserved the stripe patterning was only 160 bp in 
size. When the two enhancers were linked, however, abnormal expression 
patterns resulted. Similar effects were seen when the positions of the stripe 2 
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enhancer and the stripe 3 enhancer were switched with or without a spacer, 
although the abnormal pattern seen with the linked enhancers was different 
depending on which enhancer was positioned first. This indicated that the normal 
stripe pattern was dependent on the separation of the two stripe enhancers by 
some spacer. The position sensitivity of these enhancers differs from other 
examples of position or orientation sensitivity in that the proper function of these 
enhancers is dependent on their distance from each other, not from the TSS. 
Nonetheless, this example illustrates the idea that enhancer position can reflect the 
need for the proper genomic context. 
Many studies of cis-regulatory elements from the 1980s also uncovered 
some apparent sensitivity to changes in position or orientation. At this time, 
however, the definition of cis-regulatory elements as flexible in their position and 
orientation was newly established as a criterion for defining such an element as an 
enhancer. To satisfy this criterion, it was enough for a newly discovered enhancer 
to show that the enhancer in the altered setup still increased expression of the 
target gene to a significant extent. Many cases of substantial reduction in 
enhancer activity in these altered constructs were therefore ignored at the time. 
For example, the study by Jaynes et al. (1988) found that a muscle-specific 
enhancer located 1050 bp upstream of the muscle creatine kinase gene retained 
100% of its enhancer activity when moved to a position 80bp upstream of the 
TSS, but expression dropped to around 20% when the enhancer was either moved 
downstream of the reporter gene chloramphenicol acetyltransferase (CAT) in 
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either orientation, or inverted in orientation at the -80 position. It should be noted 
that the constructs that gave this strong decrease in expression had deletions of all 
upstream sequence excluding the enhancer element to position -80. A set of 
constructs with the enhancers in the downstream position (in either orientation) 
and with upstream deletions only to position -776 gave between 42 and 74% 
expression. The study by Shaul et al. (1985) found that an enhancer for the 
hepatitis B virus core antigen (HBcAg) promoter gave levels of CAT activity 
ranging from 50 to 300 in the forward orientation, but the enhancer in the reverse 
orientation gave CAT activity ranging from 25 to 50. These numbers are 
normalized to a comparable construct using an enhancer from simian virus 40 
(SV40), which was defined as an activity level of 100. Similarly, Laimins et al. 
(1984) found that an enhancer from the long terminal repeat of Moloney murine 
sarcoma virus gave nearly equal CAT expression in the forward and reverse 
orientations but was only 30 to 40% active when moved downstream of the CAT 
gene in either orientation. 
Elion and Warner (1986) discovered an example of position and 
orientation sensitivity in a yeast ribosomal DNA (rDNA) enhancer. The position 
sensitivity was slight; expression was just under 60% of the default position 
expression when the upstream enhancer was moved closer to the TSS or 
downstream of the target gene. The result of inversion of the enhancer was 
initially found to be a complete loss of enhancer function. However, this effect 
was further examined in the study by inverting a larger fragment consisting of the 
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correctly oriented enhancer flanked by about 750 bp of non-enhancer DNA on 
either side. The resulting vector restored enhancer activity to about 50% in spite 
of the inverted enhancer orientation in this construct. When this same larger 
inversion was performed on the test vector with the minimal enhancer already 
inverted, the resulting vector showed virtually no enhancer activity even though 
the enhancer ended up in the forward orientation. It was concluded that the 
observed loss of enhancer activity was due to a silencing effect of the fusion of 
the 3’ end of the inverted enhancer with pBR322 vector sequence normally found 
at the 5’ end of the enhancer. 
Taken together, these examples demonstrate that many enhancers show 
some sensitivity to changes in position and orientation. The degree of sensitivity 
varies from one enhancer to the next and may also depend on the nature of the 
change. Some enhancers are sensitive to changes in position but not in orientation, 
or vice versa; some enhancers also appear to show different degrees of activity 
when different combinations of position and orientation changes are introduced 
(Kim et al., 2008; Elion and Warner, 1986). In some cases (Small et al., 1993; 
Jaynes et al., 1988; Elion and Warner, 1986) the activity of an enhancer was 
found to be influenced by other nearby sequence elements, which may point to a 
universal explanation of why certain enhancers are only fully functional in the 
naturally occurring position or orientation. 
Aside from a misidentification of the minimal enhancer sequence, there 
are several possible ways that an enhancer could be dependent on other sequence 
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elements. Two such possibilities are discussed in the following paragraphs. One 
simple explanation is that there may be other TF binding sites outside of the 
defined minimal enhancer, and TFs bound to these external sites interact with 
enhancer-bound TFs to bring about 100% transcriptional activation. These 
external sites could be deleted or interrupted in some of the altered constructs, 
preventing the TFs from binding these sites. Conversely, if there are multiple TF 
binding DNA elements that must interact with the basal promoter through bound 
TFs, inverting or repositioning one such element, such as the enhancer, may alter 
the formation of the necessary loop structure and thereby prevent transcription.  
An alternate explanation for sensitivity to genomic context is that 
sequences flanking an enhancer may play a critical role in TF binding. In higher 
organisms, DNA exists as part of the material chromatin, a complex of the DNA 
and various bound proteins referred to as histones. Most of the DNA in chromatin 
is found in nucleosomes, which are composed of stretches of approximately 147 
bp of DNA wrapped around a core of eight histones (Segal and Widom, 2009). 
Certain DNA sequences are favorable for nucleosome formation, while other sites 
tend to remain nucleosome-free or have lower nucleosome density because the 
sequence is less favorable for nucleosome occupancy (reviewed in Segal and 
Widom, 2009). TFs cannot bind their target sites when nucleosomes occur at 
these sites, meaning that TF binding sites must either occur in nucleosome-free 
stretches of DNA or be subject to some mechanism of nucleosome displacement. 
Some DNA sequences that are unfavorable for nucleosome formation tend to 
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prevent nucleosomes from developing in flanking sequences as well, which 
means that enhancers located adjacent to nucleosome-free regions may be more 
accessible to their TFs (Segal and Widom, 2009). Altering the position or 
orientation of such an enhancer could therefore reduce TF binding.  This effect 
will often be visible using transient plasmids, in which the DNA appears to form 
nucleosomes in a normal fashion, although higher order chromatin structures may 
differ from those seen in the correct genomic context (Hebbar and Archer, 2008).  
Changes in enhancer position or orientation may affect processes 
other than target gene expression. There have been a few studies that have 
linked changes in enhancer position or orientation to deficiencies in processes not 
related to gene expression. One such study was performed by Bachl et al. (1998). 
The focus of this study was the intronic enhancer for the heavy (H) chain of the 
immunoglobulin (Ig) gene, specifically the role of this enhancer in hypermutation 
in the variable (V) region of the H chain. For this study the Ig basal promoter was 
replaced with a thymidine kinase (tk) promoter fused to the SV40 enhancer; this 
chimeric promoter had previously been found to work in hypermutation 
experiments. The rest of the Ig gene was left intact. Deletion of the intronic 
enhancer caused a roughly 100-fold decrease in the mutation rate, showing that 
this enhancer is necessary for the natural hypervariability of the V region. 
Similarly, a construct with the intronic enhancer in the reverse orientation showed 
a 10-fold drop in the mutation rate, and there was a 7-fold drop in mutation 
frequency when the enhancer was repositioned 3’ of the entire V region. These 
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decreases in hypermutation were not accompanied by changes in H chain 
expression, since the levels of mRNA produced from these different constructs 
appeared to be close to equal on a gel. 
 Another study by Chandrasekharappa and Subramanian (1987) focused 
on the connection between the 72-bp-repeat enhancer in SV40 and the process of 
DNA replication. One significant finding of this study was that DNA replication 
at the SV40 core replication origin was dependent upon the distance between this 
core origin and the 72-bp-repeat enhancer. The core origin and enhancer are 
separated by less than 100 bp in SV40. Compared to a vector with the SV40 core 
origin but without the enhancer, vectors containing both elements separated by 8 
or 9 bp gave an approximately tenfold increase in replication efficiency, while 
those containing the two elements separated by 99 bp or more gave a replication 
efficiency equal to or lower than the enhancer-less vector. The increase in DNA 
replication was not sensitive to changes in the enhancer orientation; however, it 
was found that activation of DNA replication occurred only when the end of the 
core origin containing the 17 bp A+T rich element was facing the enhancer. This 
was true regardless of whether the core origin was found in its default position or 
moved to the opposite end of the enhancer. This study also noted that the 72-bp-
repeat enhancer is not position or orientation sensitive as a transcriptional 
activator. 
Conservation of enhancer position and orientation is not a definitive 
indicator of sensitivity of that enhancer to position or orientation changes. 
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Genetic sequence conservation is a useful tool for locating genes as well as 
functional non-coding DNA elements, since preservation of sequence between 
distantly related species tends to represent selective pressure against any mutation 
in that element. Similarly, one may infer that if the position or orientation of a cis-
regulatory element is evolutionarily conserved, then the observed position or 
orientation of that element is critical for its function. This appears to be the case 
for the C. intestinalis Pax6 upstream enhancers, which show position and 
orientation conservation with Pax6 in C. savignyi (Irvine et al., 2008) and were 
found in this study to be sensitive to changes in both position and orientation. 
While C. intestinalis and C. savignyi are rather closely related species for such a 
determination of sequence conservation, Pax6 homologs such as mouse Pax6 and 
the Drosophila gene eyeless have slightly different sets of enhancers (reviewed in 
Irvine et al., 2008), making such a determination of position or orientation 
conservation impossible for these larger evolutionary distances. Other examples 
of enhancers with conserved position and orientation have shown more flexibility 
than Pax6. The study by Kim et al. (2008) noted that the position and orientation 
of the CSE1 element were evolutionarily conserved relative to the TSS in 
mammals. The orientation of the entire CSE2 element, and the orientation of all 
individual YY1 binding sites within this element, were also conserved. The 
functional analysis found that both elements were orientation sensitive, but the 
CSE1 element was clearly flexible in its position relative to the TSS. In the 
Drosophila eve gene, the promoter arrangement is conserved between D. 
 47
melanogaster and the rather distant relative D. grimshawi (Small et al., 1993). 
This conservation includes the position of the stripe 3 enhancer upstream of the 
stripe 2 enhancer; yet the positions of these two enhancers can be switched 
without a visible effect on the stripe pattern that develops. 
Examples such as these do support the logical hypothesis that enhancers 
that are sensitive to changes in position or orientation will show the corresponding 
evolutionary conservation, but not all examples of conservation point to 
inflexibility in the genomic environment. The inconsistency of this relationship 
between position or orientation conservation and position or orientation 
sensitivity creates more questions than answers. One possibility is that some of 
these conserved enhancers have other roles outside of transcriptional activation, 
and that there is some type of sensitivity to genomic context in this alternate role. 
The conserved position or orientation in these cases would be a reflection of the 
non-transcriptional function of the enhancer. This explanation is likely to apply to 
a few specific cases but is not likely to provide a general reconciliation of 
contextual conservation with position or orientation flexibility. Another 
possibility is that the flexibility seen using transgenic plasmids does not reflect the 
true genomic context of these enhancers. This could be due to differences in 
chromatin structure in the plasmid versus the genome (Hebbar and Archer, 2008), 
or it could be due to interaction of TFs that bind the enhancer with TFs bound to a 
different sequence element that was not included in the experimental plasmids. 
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 The results of this study and others create new questions about the 
nature of enhancers and other cis-regulatory DNA modules. One of the 
defining criteria of an enhancer is that it is capable of increasing expression of its 
target gene in a position- and orientation-independent manner. This idea continues 
to be well supported even by the findings of this study, although there may be 
exceptions to this definition (Kim et al., 2008). However, this definition does not 
mandate that enhancers in an altered position or orientation function as effectively 
as in their default setup. This study, along with other studies discussed earlier, 
indicate that many enhancers lose much of their activity when they are 
repositioned or inverted. This raises the questions of how widespread this trend is 
among enhancers and whether there is a pattern to which enhancers show such 
sensitivity.  
 Investigation of these new questions could begin with genomic screening 
for identified enhancer elements that show conservation in their position and 
orientation across species. Elements that show such conservation relative to their 
target genes are most likely to be sensitive to inversion or repositioning. 
Functional studies could then be employed to identify which of these enhancers 
are position or orientation sensitive. Once these enhancers have been identified, 
the next step would be to look for patterns that may explain why these enhancers 
are sensitive to position or orientation changes while others are not. It may be that 
enhancers for certain types of genes are less tolerant of changes in position or 
orientation, or sensitivity to position or orientation may reflect a dependence on 
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genomic context that is common to all of these enhancers. This type of position or 
orientation sensitivity could also have a substantial biomedical impact in cases 
where proper gene function is sensitive to the level of expression. In these cases 
inversion or repositioning of an enhancer could affect expression levels enough to 
alter the phenotype of an organism or, in the case of Pax6 or other developmental 
regulators, produce a developmental disorder. This may also explain the observed 
phenomenon of evolutionary constraint of position and orientation in certain 
enhancers. The results of these future studies will build upon our current 
understanding of how enhancers function.
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